Premium
Perspectives From the Clinic: Will the Average Physician Embrace Personalized Medicine?
Author(s) -
Levy H,
Young JH
Publication year - 2008
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/sj.clpt.6100486
Subject(s) - personalized medicine , alternative medicine , medicine , family medicine , medical education , bioinformatics , pathology , biology
In 1961, Richard Asher argued that the clinical question regarding a particular intervention is not “ should it work?” but rather “ does it work?”. 1 , 2 , 3 Since that time, clinical trials have become the cornerstone of clinical science, providing physicians access to an expanding pharmacopeia of therapeutic options. The new capacity to change the course of illness has transformed patients’ lives as well as the clinical encounter. The recent call for personalized medicine is an attempt to further our therapeutic effectiveness. Clinical Pharmacology & Therapeutics (2008) 83 , 3, 492–493.doi: 10.1038/sj.clpt.6100486